Wall Street Splits as a Mega-Cap AI Unwind Sinks the Nasdaq 1.1% and Alphabet Loses 6% — but the Dow Climbs 167 Points

Wall Street opened the post-Juneteenth week split down the middle, and the split tells the whole story. The S&P 500 sat at 7,473.58 around midday, off about 27 points, or 0.36%, after closing Thursday at 7,500.58. The Nasdaq Composite got smoked, down roughly 1.1% to near 26,230 from its 26,517.93 close. And the Dow Jones Industrial Average shrugged the whole thing off, adding about 167 points, or 0.3%, to trade near 51,730 after finishing Thursday at 51,564.70. Three indexes, three directions, on the same headlines.

That divergence is not noise. It is money rotating, not money fleeing. The mega-cap AI complex that carried this market all year is coming undone at the top — Alphabet down 6%, Amazon off 4%, Meta lower by 3%, Microsoft down about 2% — while everything underneath catches a bid. Small caps firmed, the Dow's industrial and financial ballast held green, and the VIX barely flinched at 16.78. This is not a panic. It is a reallocation, and the crowd is finally trimming the most crowded trade on the board.

The backdrop is constructive on paper. Over the weekend, US and Iranian negotiators reported "encouraging progress" in Switzerland and agreed to a roadmap toward a final deal inside 60 days. Goldman Sachs cut its US recession odds to 15% on the de-escalation. Oil fell again, with crude off about 2.73%, after the Treasury authorized Iranian oil sales through August. By every macro measure, this should be a risk-on Monday.

Instead, the index leadership inverted. The thesis driving today's session is simple: investors are pulling capital out of the AI hyperscalers — names whose capex bills have ballooned faster than anyone can model a return on — and pushing it into chips, into value, into deal stocks, and into small caps. Micron rose 4% into Wednesday's earnings. Apogee Therapeutics ripped 47% on a buyout. The bid did not leave the market. It moved.

What hangs over all of it is Thursday's PCE inflation print, the Fed's preferred gauge, landing five days after Kevin Warsh's first meeting as chair delivered a hawkish hold. That report is the verdict on whether this rotation has legs or whether the whole tape rolls over.

Alphabet Gets Smoked: A 6% Drop and the Brain-Drain Story

Alphabet was the single heaviest weight on the S&P 500 and the Nasdaq, with shares sliding roughly 6% to near $343 from Thursday's $368.03 close. At the morning lows the stock printed $341.72, and it traded as low as a 6.8% decline. That puts GOOGL about 16% below its May 18 all-time high of $408.61, a steep de-rating for a company whose business is, by the numbers, accelerating.

The proximate trigger was talent. Noam Shazeer — a co-author of the 2017 "Attention Is All You Need" paper that birthed the transformer architecture and a VP co-leading Gemini — announced he is leaving for OpenAI. That is the kind of departure that spooks a market already nervous about whether Google can hold its frontier-model edge. The headline crossed into a tape that was hunting for a reason to sell the most expensive AI bets, and it got one.

The deeper anxiety is the spending. Alphabet has guided 2026 capital expenditure to a range of $180 billion to $190 billion, roughly double 2025's level, with management flagging even higher outlays in 2027. That build is crushing free cash flow — down sharply year over year in Q1 — and the company's $84.75 billion equity raise, backed by a $10 billion Berkshire Hathaway placement, layered fresh dilution on top and effectively paused the buyback. Investors are asking the only question that matters: when do these data centers pay for themselves?

Regulation piled on. A California judge denied Google and Meta a new trial in a case alleging their platforms were engineered to be addictive for young users, keeping Alphabet exposed to damages and copycat suits. The UK government, meanwhile, is moving to ban social media for under-16s and tighten chatbot rules, with YouTube squarely in the crosshairs. None of that is fatal, but it is a steady drip of overhang on a premium-valued name.

Here is the disconnect: the business is not breaking. Q1 2026 revenue hit $109.9 billion, up 22%, with Google Cloud growing 63% and a contracted backlog of $460 billion — more than Alphabet earns in a full year. The stock is getting repriced on capex and headlines, not on demand. That is exactly the kind of dislocation that either marks a top or sets up a vicious snap-back, and the tape has not decided which.

The Hyperscaler Unwind: Amazon, Meta, and Microsoft Join the Slide

Alphabet did not fall alone. The entire hyperscaler cohort got dragged lower in lockstep, and that is what turned a single-stock story into an index event. Amazon dropped 4%, Meta Platforms lost 3%, and Microsoft shed about 2% after trading down 1.5% early. Four names, hundreds of billions in market cap, all bleeding on the same fear.

The fear has a name: capital intensity. The hyperscalers have collectively committed to spending that runs into the trillions through 2030 on compute, data centers, and power. For two years the market cheered every dollar. Now it is squinting. Jim Cramer put it bluntly over the weekend, arguing the AI trade has left the hyperscalers "in the dust" — the spending is real, the revenue is real, but the gap between what these companies are pouring into infrastructure and what they are pulling out the other end has stopped being a rounding error.

That skepticism showed up in the relative tape. Over the past 30 days, Amazon and Microsoft both fell roughly 7%, while Apple — which is not carrying the same capex load — held essentially flat, up 0.5%. The market is drawing a line between the companies writing the biggest checks and the ones collecting the rent. Chip suppliers and memory makers, the names actually selling the picks and shovels, are the beneficiaries.

This is the cleanest expression of the day's rotation. The capital coming out of GOOGL, AMZN, META, and MSFT is not leaving equities. It is moving down the AI food chain to the suppliers, sideways into value, and into the small-cap names that have lagged the mega-cap melt-up all year. The Nasdaq's 1.1% drop is almost entirely a function of these four stocks; strip them out and the index is roughly flat.

The risk is reflexive. When the largest index components all sell at once, passive flows amplify the move, and the selling feeds itself regardless of fundamentals. That is why the Nasdaq is the worst-performing major index today even though most of its members are not down. Concentration cuts both ways, and right now it is cutting against the bulls.

SpaceX Bleeds a Third Straight Day: $20 Billion in Bonds and a Thin Float

The hottest IPO in market history is now its hottest unwind. SpaceX fell about 8% on Monday, on pace for its third consecutive losing session, with shares changing hands near $169 to $176 after a premarket print around $175.73. The stock listed at $135 on June 12, exploded to an all-time high of $225.64 on June 16 — briefly vaulting past Amazon and Microsoft in market value — and has been giving it back ever since. Even after the slide, SPCX still trades roughly 37% above its IPO price.

Monday's catalyst was the balance sheet. SpaceX announced an offering of senior unsecured notes — a debt deal Bloomberg pegged at $20 billion or more — and disclosed it held $100.8 billion in cash and equivalents as of June 19. That sequence rattled investors: a company that just raised about $75 billion in its IPO, announced a $60 billion acquisition of AI coding firm Anysphere, and is now borrowing another $20 billion invites one obvious question — how much capital does this business actually need?

The mechanics make the moves violent. Only about 4% to 5% of SpaceX shares trade freely; the rest is locked up. That razor-thin float is what produced the explosive debut, and it cuts hard in reverse — modest selling drops the price several percent because there is not enough resting liquidity to absorb it. Options began trading June 17, finally handing short sellers a practical way to bet against the name.

The fundamentals carry real risk. SpaceX posted a $4.9 billion net loss in 2025 and another $4.28 billion in Q1 2026, driven by xAI, which it merged with in February and which is burning cash on enormous capex. Starlink remains profitable and growing, but the AI division is eating those profits. MSCI handed the company its lowest possible ESG rating — a CCC — and KeyBanc initiated coverage Monday at Sector Weight with no price target. Analyst targets span a comical range, from $62 to over $300.

The overhang ahead is the lock-up. The standard 180-day expiry lapses near December 2026, and Musk's roughly 6.4 billion shares stay locked until June 2027. The same thin float that drove the melt-up could work in reverse when supply arrives. For now, SPCX is doing exactly what a freshly listed, scarcity-priced stock does: swinging 10% in a session and reminding everyone that price discovery is a contact sport.

Micron Is the Swing Trade: Chips Rip Into Wednesday's Print

While the hyperscalers bled, the chipmakers ripped, and that contrast is the rotation in one frame. Micron led the tape's winners among large caps, gaining about 4% to trade near $1,180 after a $1,168.46 premarket print and Thursday's $1,133.99 close. The stock is up roughly 298% year to date and an absurd 830% over the past twelve months, riding the tightest supply-demand setup in the memory industry's history.

The reason is high-bandwidth memory. AI accelerators need HBM stacked alongside the GPU, and only three companies on earth — Micron, SK Hynix, and Samsung — make it at scale. That oligopoly has handed Micron pricing power it never had as a commodity DRAM maker. HBM4 is already shipping in volume, and Micron is a qualified supplier for Nvidia's Vera Rubin platform, the Blackwell successor that packs up to 384 GB of HBM4 per GPU.

The whole setup hinges on Wednesday. Micron reports fiscal Q3 results June 24 after the close, with consensus around $33.5 billion to $34.7 billion in revenue and adjusted EPS near $19.72 to $20.57. Analysts have been falling over each other to raise targets — Bernstein lifted its number 155%, Rosenblatt went from $600 to $1,200, Wedbush stayed at $1,300 — but the bar is now brutal. With the stock up 830% in a year, a beat is priced in. Micron has to beat and raise, or the post-print reaction could be ugly regardless of how good the quarter is.

The valuation, oddly, is not the stretched part of this story. Micron trades under 10 times forward earnings with a PEG near 0.07, far cheaper than AI peers like Broadcom. The risk is not the multiple; it is the cycle. If hyperscalers buy less HBM or train models more efficiently than expected, demand could soften before Micron's new $25 billion-plus in fiscal 2026 capacity comes online. Memory has crashed after every boom in its history.

The read-through is broad. The Philadelphia Semiconductor Index sits at a record, and memory peers including Seagate, Western Digital, and Sandisk caught a bid Monday. MarketWatch noted that stripping out Micron and Nvidia would cut Q2 S&P 500 earnings growth from 22% to 14.9%. Two stocks. That is how much this market leans on the memory and GPU trade, and why Wednesday's print is the most important event on the calendar before Thursday's PCE.

AbbVie Buys Apogee: A 47% Pop and the Return of the M&A Bid

The deal tape woke up, and it woke up loud. Apogee Therapeutics rocketed about 47% after AbbVie agreed to acquire the immunology drug developer for $135.11 per share in cash, valuing the company at roughly $10.9 billion. The boards of both firms approved unanimously, and the transaction is expected to close in the third quarter, subject to shareholder and regulatory approval. AbbVie shares added about 1% on the news.

The strategic logic is clean. Apogee's lead asset, zumilokibart, is a half-life-extended monoclonal antibody targeting IL-13 in development for atopic dermatitis, and its pipeline includes APG273, a long-acting combination aimed at asthma with the potential for quarterly or twice-yearly dosing. The acquisition deepens AbbVie's immunology franchise and pushes it into respiratory disease. AbbVie expects the deal to turn accretive to adjusted EPS beginning in 2032, and there is no financing condition attached — the company is paying cash and guaranteeing its subsidiaries' obligations. The reciprocal termination fee runs to about $381 million.

Apogee was not the only buyout mover. Arcosa surged 7.4% after CRH, the building-materials giant, agreed to acquire it in an all-cash deal valued at $150 per share. Two clean, premium, all-cash takeouts in a single session is a signal worth noting: corporate acquirers are looking at the recent pullback in growth and biotech names and deciding the prices are right.

That matters for the broader thesis. M&A returning at premium multiples is the opposite of a market in distress. When boards greenlight $10.9 billion cash deals and pay up for clinical-stage pipelines, they are betting on stability, not bracing for a downturn. It puts a floor under sentiment in the exact corners — biotech, mid-cap industrials — that have lagged the AI mega-caps.

The contrast with the hyperscaler unwind is the point. On the same day Alphabet shed 6% on capex fears, AbbVie wrote a $10.9 billion check without blinking and the market applauded. Capital is not scarce and risk appetite is not gone. Both are simply being redirected away from the most expensive, most crowded trade and toward situations where the math is legible. That is rotation, not retreat, and the deal tape is the cleanest evidence of it.

Gold Miners Get Hit: Alamos, AngloGold, and the Safe-Haven Unwind

If you want proof the market read the Iran headlines as genuinely de-escalatory, look at the gold complex, because it got crushed. Alamos Gold tumbled 12.3% and AngloGold Ashanti fell 6.5% as the metal sold off hard alongside silver. Miners are leveraged plays on the underlying, and when gold rolls over, the equities roll harder.

The logic is straightforward. Gold ran all year on geopolitical fear — the Iran conflict that began in February drove a steady safe-haven bid into bullion and the producers that mine it. A roadmap to a final peace deal inside 60 days, a 15% recession probability from Goldman, and a risk-on rotation into equities pull the props out from under that trade. When the fear premium deflates, the first thing to give back its gains is the asset that rallied on fear in the first place.

A double-digit drop in a major producer like Alamos in a single session is not a gentle repricing. It is a stampede out of a crowded hedge. Investors who piled into gold and miners as insurance against a Middle East blowup are unwinding that insurance now that the blowup looks less likely, and they are doing it fast. The 12.3% decline in AGI and the 6.5% drop in AU are the cost of being long the wrong narrative on the wrong day.

There is a rate dimension too. Gold pays no yield, so it competes directly with cash and Treasuries. With the Fed signaling a hawkish hold and nearly half of FOMC members now penciling in a hike before year-end, the opportunity cost of holding a non-yielding metal is rising. Higher-for-longer rates are a persistent headwind for bullion, and the Iran de-escalation simply gave the trade a reason to crack today.

The miners' pain is the rotation's mirror image. The same de-escalation that hammered gold producers is what cut crude, lifted the recession-odds picture, and gave the Dow its green print. Every one of these moves is the same trade viewed from a different angle: fear coming out, risk going back on. Gold miners are simply the most violent expression of it, and anyone long the safe-haven complex got a brutal reminder that insurance loses value the moment the danger fades.

Oil Slides Again: Iran's 60-Day License and the Hormuz Overhang

Crude extended its retreat, falling about 2.73% on Monday as the energy market priced in the prospect of Iranian barrels coming back online. The Treasury authorized Iranian oil sales through August, with Secretary Scott Bessent disclosing a temporary 60-day general license permitting the production, delivery, and sale of Iranian oil as part of the negotiating framework. More supply, less geopolitical risk premium, lower prices — the equation is mechanical.

This is a continuation of a move that began earlier in the month. When the initial US-Iran framework emerged, US crude fell about 5% to near $80 a barrel on expectations the Strait of Hormuz — the chokepoint for roughly a fifth of global oil — would reopen. Monday's license made that supply story concrete, and crude gave back more ground.

The cross-asset effects are everywhere. Lower oil is a tailwind for the airlines and cruise operators that burn fuel as their largest variable cost, and it is a direct headwind for the energy producers. In prior sessions on this same theme, names like APA, Devon Energy, Marathon Petroleum, and EOG Resources sold off more than 3%, while Chevron and Exxon Mobil fell over 2.5%. Cheaper crude also feeds straight into the inflation math, easing headline pressure right as the market braces for Thursday's PCE.

The risk is that none of this is settled. President Trump threatened fresh strikes if Hezbollah continues its attacks on Israel and warned Tehran against any move to close the Strait of Hormuz again. Iranian media reported Tehran briefly suspended negotiations in response, though sources insisted talks remained ongoing. The 60-day license is exactly that — 60 days — and a temporary authorization tied to a fragile framework is not a durable supply shift.

So oil is caught between a genuine de-escalation and a live tail risk. The base case the market is trading is that barrels flow, the Strait stays open, and crude drifts lower. But the Hormuz overhang has not vanished; it has been deferred. Any breakdown in the talks, any escalation around Hezbollah, and the risk premium snaps back into crude overnight. For now, energy bulls are on the wrong side of the de-escalation trade, and the tape is rewarding the airlines instead.

The Iran Framework in Real Time: Progress, Threats, and a 60-Day Clock

The single most important macro variable on the board is the US-Iran negotiation, and Monday delivered the contradictory mix that has defined it all along: real progress shadowed by real risk. Over the weekend in the Swiss resort of Bürgenstock, both sides reported "encouraging progress," with a high-level committee agreeing to a roadmap toward a final deal within 60 days. Iran's foreign minister described "major progress." That is the constructive headline that set the risk-on frame.

The market took it seriously. Goldman Sachs cut US recession odds to 15% on the de-escalation. Crude fell. Gold cracked. The Dow held green. Treasury's 60-day oil license was a concrete, tradeable signal that Washington expects the framework to hold long enough to matter. By every cross-asset measure, investors are positioning for peace.

But the same day carried the counter-headline. Trump threatened renewed strikes if Hezbollah keeps attacking Israel and explicitly warned Iran against closing the Strait of Hormuz. Iranian media said Tehran suspended talks in response before sources walked it back to "ongoing." This is the pattern: a step forward, a threat, a wobble, a clarification. The path to a signed deal runs through exactly this kind of brinkmanship, and the market has learned to trade the trend rather than every twitch.

Context matters here. This conflict began in February, and the S&P 500 has risen more than 10% since the war started — a market that climbed a wall of geopolitical worry precisely because each escalation eventually resolved into negotiation. The framework Trump called "complete" in mid-June, with a memorandum of understanding slated for formal signing in Switzerland, is the culmination of months of this dance.

The trade is asymmetric and investors know it. If the 60-day roadmap holds, the risk premium keeps draining out of oil and gold, the recession odds stay low, and the rotation into risk has room to run. If it breaks — if Hezbollah forces Trump's hand or Iran moves on Hormuz — crude gaps higher, gold snaps back, and the whole risk-on tape reverses in a session. Monday's split market is, in part, the sound of investors trying to price a binary outcome that is still very much undecided.

Starmer Walks: A UK Shock the Tape Mostly Shrugged Off

The day's biggest political surprise came from London, not Washington. UK Prime Minister Keir Starmer announced his resignation as Prime Minister and Labour Party leader outside Number 10 on Monday morning, a development that would have rattled markets in another era but barely registered on Wall Street. The pound slipped just 0.19% against the dollar to $1.3207, and the yield on 10-year gilts held flat at 4.8452%.

The muted reaction tells you the move was largely priced in. Gilt yields had jumped on Friday as the resignation became increasingly likely, so by the time Starmer made it official, the market had already absorbed the shock. A leadership change at the top of a G7 government is significant, but a telegraphed one rarely moves global risk assets the way an unexpected one would.

For US investors, the relevance is mostly secondary. A weaker pound and a UK political vacuum feed into the broader currency and rates picture, but they are not the driver of the American tape today. The dollar's behavior matters more for multinationals' translated earnings than any single foreign leadership transition, and a sub-0.2% move in sterling is barely a blip.

There is a sector wrinkle worth flagging. The same UK government had been moving aggressively on social-media regulation — a proposed ban on platforms for under-16s, teen curfews, and tighter chatbot rules — with YouTube, Meta, Pinterest, Reddit, and Snap all named as targets. A change in leadership introduces uncertainty about whether that regulatory agenda accelerates, stalls, or shifts. For Alphabet and Meta, already under pressure Monday, the UK political reset is one more variable in an already crowded risk picture.

The broader lesson is about what this market chooses to care about. A G7 prime minister resigned, and the S&P moved less than half a percent on its own domestic rotation instead. The tape is laser-focused on AI capex, chip earnings, the Iran framework, and Thursday's inflation print. Everything else — even a Downing Street resignation — is background noise until proven otherwise. That selectivity is itself a sign of a market with firm convictions about what is actually moving the needle right now.

The Rebalance: Nasdaq-100 and S&P 500 Reshuffle the Decks

Monday was not a normal Monday for index mechanics. Both the S&P 500 and the Nasdaq-100 ran their scheduled quarterly rebalances at the open, because June 19 was the third Friday of the month and June 22 was the first trading day after. The Nasdaq-100 swapped in five companies and dropped five; the S&P 500 added two and removed two. The Dow, which changes only by committee on no fixed schedule, stood pat.

The composition of the changes is the tell. The Nasdaq-100 additions leaned hard toward companies supplying AI computing — the picks-and-shovels names benefiting from the same buildout that is pressuring the hyperscalers. It was also the first rebalance to use the new membership process Nasdaq introduced in May 2026, shifting to a rank-based review that can run throughout the year rather than centering on the December reconstitution.

For anyone holding a fund built on these indexes, the exposure changed inside the product with nothing to do on their end. Invesco's QQQ, which tracks the Nasdaq-100 and held about $493 billion in market value as of June 18, and the lower-cost QQQM automatically reflect the new membership. The same applies to the S&P 500 trackers. The rebalance reshuffles weights and constituents; it does not require the end investor to lift a finger.

The mechanical flows matter on the day. Rebalances force index funds to buy the additions and sell the deletions at the open, which can amplify volume and price swings in the affected names regardless of any fundamental news. Some of Monday's choppiness in individual stocks is simply the plumbing of passive money repositioning to match the new index definitions, not a verdict on any company.

It is worth stating plainly what inclusion does and does not mean. Being added to the Nasdaq-100 or S&P 500 is not a buy rating, and removal is not a sell rating. The decisions follow published methodology — primarily size and eligibility — not a judgment on business quality. Inclusion can lift a stock's visibility and bring passive ownership, but it says nothing about whether the price is attractive. The next scheduled windows for both indexes fall in September, again tied to the third Friday.

The Fed Shadow: Warsh's Hawkish Hold and a Market That Bought It Anyway

Everything Monday sits in the shadow of last week's Federal Reserve meeting, the first under new Chair Kevin Warsh, and it was a genuinely hawkish hold. The Fed left rates unchanged at a target range of 3.5% to 3.75%, which the market expected. What it did not fully expect was the posture: in the dot plot, nine of the 18 participating policymakers now project at least one rate hike before the end of 2026. Any easing bias was gone.

The reaction at the time was brutal. The Dow lost more than 500 points on the announcement day, and the S&P 500 suffered its worst "Fed day" under a new chair since 1994. Warsh, a longtime critic of the Fed's over-communication, stripped the post-meeting statement to just 130 words, declined to add his own dot to the plot, and described the economy as expanding at a solid pace while vowing to deliver price stability. The message landed as a central bank tilting toward tightening, not loosening.

The inflation backdrop justifies the hawkishness. Inflation climbed to 4.2% in May, more than double the Fed's 2% target, and Warsh has reiterated that prices remain far too high. Components of the prior month's producer-price data that map into PCE suggested a firm print ahead. A Fed staring at 4.2% inflation and a solid labor market has little reason to cut and a credible case to hike.

Yet the remarkable part is how fast the market recovered. After the Fed-day plunge, equities clawed back the losses and then some — the Nasdaq rose 2.43% last week, the S&P added 0.93%, and the Dow gained 0.71%. Chip stocks led the comeback. Investors digested the hawkish hold, decided the AI growth story and the Iran de-escalation outweighed the rate risk, and bought the dip with conviction.

That sets up the tension defining this tape. A hawkish Fed is a headwind for every long-duration growth stock, and the mega-cap unwind Monday is partly the market acknowledging that higher-for-longer rates compress the multiples of the most expensive names. But the same market keeps buying chips and small caps and deal stocks, betting growth and de-escalation win. Thursday's PCE is the referee. A hot print validates the hawks and pressures the whole complex; a soft one hands the bulls their rotation and lets the dip-buyers keep winning.

This Week's Gauntlet: PMIs, PCE, and the Inflation Verdict

The calendar is the catalyst from here, and it is loaded. Monday itself was quiet on data, but the docket escalates fast. Tuesday brings the S&P Global Flash PMIs for June, the first read on whether business activity held up through the month. Wednesday delivers May new home sales alongside Micron's earnings after the close and Nvidia's annual shareholder meeting, where Blackwell ramp and the first in-house Vera CPU will draw intense focus.

Thursday is the main event. May personal income and spending land together with the May PCE price index — the Fed's preferred inflation gauge — plus May durable goods orders and the final estimate of first-quarter GDP. After a hawkish hold and 4.2% headline inflation, this PCE print is the most consequential data point of the month. A firm number cements the case for a 2026 hike and pressures every rate-sensitive corner of the market; a cool one gives the rotation room to run. Friday closes the week with the University of Michigan's revised June consumer sentiment and inflation expectations.

Underneath the headline indexes, the rotation showed up in breadth. Small caps outperformed sharply, with the Russell 2000 firmer even as the Nasdaq sank — exactly the kind of leadership reversal you see when money rotates out of crowded mega-caps and into the laggards. Rate-sensitive names told a mixed story: AvalonBay Communities slipped 3.9% as REITs stayed under pressure from the higher-for-longer rate picture, while value and industrial names anchored the Dow's green session.

The VIX at 16.78 is the most important tell of all. A 1.1% drop in the Nasdaq driven by a coordinated mega-cap unwind, on a day with a G7 resignation and live Iran brinkmanship, and volatility barely moved. That is not a market bracing for a crash. It is a market calmly repricing leadership while keeping its overall risk appetite intact. Fear is not in this tape.

Single-stock noise rounded out the session: Palantir slipped 1.5% to $126.58, and Lucid fell 2.1% after announcing an 18% cut to its US workforce for roughly $158 million in annualized savings, with its COO departing. These are the idiosyncratic stories that fill out a rotation day — none of them moving the index, all of them part of the texture.

The Setup: What Has to Hold

Strip away the headlines and Monday's tape is a single, coherent move: capital rotating out of the most crowded AI mega-caps and into everything they have left behind. The S&P 500 at 7,473.58 and the Nasdaq's 1.1% slide are almost entirely the work of four stocks — Alphabet, Amazon, Meta, Microsoft — shedding a combined fortune on capex fear and a brain-drain headline. The Dow's 167-point gain, the firm small caps, the 47% pop in Apogee, the 4% rip in Micron, and the bid under value are the other side of that same trade. Money moved; it did not leave.

The levels to watch are clean. The S&P held above 7,470 and well clear of last Wednesday's 7,420.10 low, the line that defines whether this is a healthy rotation or the start of something worse. The Nasdaq's 26,021.66 print from June 17 is the floor that matters for the tech tape. Lose those, and the rotation curdles into a broader risk-off. Hold them, and the dip-buyers who reclaimed last week's losses get the benefit of the doubt again.

Three events decide the next leg. Micron's print Wednesday is the verdict on whether the chip leadership that is absorbing hyperscaler outflows can keep carrying the tape — a stock up 830% in a year has to beat and raise or it cracks. Thursday's PCE is the verdict on the Fed, on rates, and on every long-duration multiple in the market. And the Iran framework's 60-day clock is the verdict on the risk premium draining out of oil and gold.

The bull case is intact as long as the rotation stays a rotation. A market that can absorb a 6% drop in Alphabet, an 8% slide in the most hyped IPO ever, a G7 resignation, and live Middle East brinkmanship — all while the VIX sits at 16.78 and the Dow trades green — is a market with conviction, not one in retreat. The AI mega-cap unwind is real, but it is a repricing of leadership, not a repudiation of equities.

The bear case is concentration. The same four names that dragged the index Monday can drag it every day until the capex question gets an answer, and passive flows amplify every move. If PCE runs hot and Micron disappoints, the rotation has nowhere left to rotate, and the floor gives way. For now, the tape is doing the healthiest thing a richly valued market can do — broadening out — and Thursday tells us whether it holds.

That's TradingNEWS